Get the Stockscreener App
10.29
0.05%
0.005
After Hours:
10.30
0.005
+0.05%
Drugs Made In America Acquisition Corp stock is traded at $10.29, with a volume of 2,852.
It is up +0.05% in the last 24 hours and down -0.05% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.29
Open:
$10.3
24h Volume:
2,852
Relative Volume:
0.07
Market Cap:
$345.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.24%
1M Performance:
-0.05%
6M Performance:
+2.64%
1Y Performance:
+0.00%
1-Day Range:
$10.29
$10.30
1-Week Range:
$10.26
$10.34
52-Week Range:
$9.96
$10.34
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
954-870-3104
Address
2 PELICAN DR., FORT LAUDERDALE
Compare DMAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.29 | 344.89M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.09 | 1.73B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
CCCX
Churchill Capital Corp X
|
25.95 | 1.17B | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
9.995 | 588.75M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.39 | 559.40M | 0 | 0 | 0 | 0.00 |
|
HOND
Hcm Ii Acquisition Corp
|
21.00 | 542.23M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Chart based exit strategy for Drugs Made In America Acquisition Corp.Earnings Summary Report & Fast Moving Trade Plans - newser.com
What technical models suggest about Drugs Made In America Acquisition Corp. Equity Right’s comebackTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Top chart patterns to watch in Drugs Made In America Acquisition Corp.July 2025 Update & Consistent Return Strategy Ideas - newser.com
How to read the order book for Drugs Made In America Acquisition Corp.Gold Moves & Weekly Top Gainers Alerts - newser.com
Using data models to predict Drugs Made In America Acquisition Corp. stock movementJuly 2025 Summary & Accurate Technical Buy Alerts - newser.com
Ranking Drugs Made In America Acquisition Corp. among high performing stocks via toolsBreakout Watch & Safe Swing Trade Setups - newser.com
Can swing trading help recover from Drugs Made In America Acquisition Corp. lossesOil Prices & High Conviction Buy Zone Alerts - newser.com
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica
How to interpret RSI for Drugs Made In America Acquisition Corp. stockJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Does Drugs Made In America Acquisition Corp. stock trade at a discount to peersShort Setup & Daily Risk Controlled Trade Plans - newser.com
What’s next for Drugs Made In America Acquisition Corp. stock priceQuarterly Portfolio Report & Consistent Growth Stock Picks - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Drugs Made In America Acquisition (NASDAQ:DMAA) - MarketBeat
Drugs Made In America Acquisition Corp Equity Right Stock Analysis and ForecastDividend Yield Trends & Free Expert Guidance For Growth - earlytimes.in
Analyzing Drugs Made In America Acquisition Corp. Equity Right with multi timeframe charts2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-09 03:21:12 - newser.com
Why Drugs Made In America Acquisition Corp. Equity Right is moving todayTrade Exit Summary & Consistent Return Investment Signals - newser.com
Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ - Seeking Alpha
Trump Wants to Overhaul Drug Sales. A Company Tied to His Son Stands to Benefit. - The Wall Street Journal
Regression analysis insights on Drugs Made In America Acquisition Corp. performance2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
Key metrics from Drugs Made In America Acquisition Corp.’s quarterly data2025 Performance Recap & AI Driven Stock Reports - newser.com
Will Drugs Made In America Acquisition Corp. stock go up soonCPI Data & Weekly Breakout Stock Alerts - newser.com
Canadian tech helped U.S. strike alleged Venezuelan drug boats: report - CBC
Should you wait for a breakout in Drugs Made In America Acquisition Corp. Equity RightJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Why Drugs Made In America Acquisition Corp. stock remains undervalued2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Is Drugs Made In America Acquisition Corp. stock bottoming outMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Should You Watch Oil and Natural Gas Corporation Limited for Sector Rotation UpsideStock Buy Signals & Reinvest for Maximum Compounding Returns - earlytimes.in
Tick level data insight on Drugs Made In America Acquisition Corp. Equity Right volatilityJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-03 05:28:21 - newser.com
Will Drugs Made In America Acquisition Corp. Equity Right stock attract ESG investorsStock Surge & Momentum Based Trading Signals - newser.com
Drugs Made In America Acquisition II Corp. completes $500 million IPO and private placement - Investing.com
What analysts say about Drugs Made In America Acquisition Corp stockTechnical Pattern Recognition & These 3 Stocks Could Change Your Portfolio - earlytimes.in
PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 b - The Economic Times
Published on: 2025-09-30 03:25:06 - newser.com
What analysts say about Drugs Made In America Acquisition Corp Equity Right stockEvening Star Patterns & Investor Community Interactions - earlytimes.in
IPO Roundup: Drugs Made in America Acquisition, FBS Global and more - MSN
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):